About Stilla Technologies
Stilla Technologies is a company based in Villejuif (France) founded in 2013 by Clement Gay and Remi Dangla was acquired by Bio Rad in February 2025. Stilla Technologies has raised $53.11 million across 6 funding rounds from investors including Eurazeo, Bio Rad and European Investment Bank. Stilla Technologies offers products and services including Nio® dPCR, Digital PCR Kits and Assays, and Custom Assay Design Service. Stilla Technologies operates in a competitive market with competitors including GenMark Diagnostics, Silicon Biosystems, Sense Biodetection, Mesa Biotech and Quantalife, among others.
- Headquarter Villejuif, France
- Founders Clement Gay, Remi Dangla
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stilla Technologies
Stilla Technologies offers a comprehensive portfolio of products and services, including Nio® dPCR, Digital PCR Kits and Assays, and Custom Assay Design Service.
Instrument for high-capacity DNA quantification and mutation detection
Kits for targeted mutation detection in various samples
In silico design and testing for personalized assays
Funding Insights of Stilla Technologies
Stilla Technologies has successfully raised a total of $53.11M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $12.73 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Stilla Technologies
Stilla Technologies has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurazeo, Bio Rad and European Investment Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health tech startups are invested in by Illumina Ventures.
|
Locked | Locked | Locked | |
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked |
Investor details for Stilla Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stilla Technologies
Investment portfolio details for Stilla Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stilla Technologies
Detailed financials for Stilla Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stilla Technologies Comparisons
Peer comparison for Stilla Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stilla Technologies
Stilla Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenMark Diagnostics, Silicon Biosystems, Sense Biodetection, Mesa Biotech and Quantalife, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| Locked | Locked | Locked |
Provider of point of care molecular diagnostics solutions
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostic kits are developed and supplied.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
Detailed competitors of Stilla Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stilla Technologies
Complete news archive for Stilla Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stilla Technologies
Stilla Technologies was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Stilla Technologies is headquartered in Villejuif, France.
Remi Dangla is the current CEO of Stilla Technologies. They have also founded this company.
Stilla Technologies is a funded company, having raised a total of $53.11M across 6 funding rounds to date.
Stilla Technologies was founded in 2013 in Villejuif, France, within the biotechnology sector. Digital PCR systems for research applications are provided, operating on Crystal Digital PCR principles in a compact format with single consumables. Data analysis is supported by Crystal Miner software, which identifies positive and negative droplets across three fluorescence channels. Operations focus on reliable tools for scientific workflows.
Stilla Technologies's top competitors include GenMark Diagnostics, Silicon Biosystems and ReadyGo.
Stilla Technologies offers Nio® dPCR, Digital PCR Kits and Assays, and Custom Assay Design Service.
Stilla Technologies has 13 investors. Key investors include Eurazeo, Bio Rad, European Investment Bank, Idinvest Partners, and Kurma Partners.